Cargando…

Cyclophosphamide-glucocorticoids versus lenalidomide-dexamethasone as treatment for multiple myeloma at first relapse after autologous stem cell transplantation – a retrospective analysis

There have been significant improvements in therapeutic options for relapsed multiple myeloma (MM) over the past two decades, with many novel agents including proteasome inhibitors, immunomodulatory agents, and more recently monoclonal antibodies demonstrating efficacy in this setting. However, ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Sterrett, Russell, Figueiredo, Amarilis, Mallick, Ranjeeta, Kekre, Natasha, Atkins, Harold, McCurdy, Arleigh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573024/
https://www.ncbi.nlm.nih.gov/pubmed/32967806
http://dx.doi.org/10.1016/j.htct.2020.07.007